UNSPSC 51124302: Quinidine

This classification denotes a cation channel blocker and antimalarial agent with the molecular formula C20H24N2O2.C6H12O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) R6875N380F, chemically known as quinidine, d-gluconate (salt) but more generally known as quinidine gluconate, which bears US NIH Compound Identifier 64642. European Medicines Agency schedules Quinidine gluconate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04170MIG.

Most nations, for tariff and trade purposes, schedule quinidine under HS 29392000 and SITC 54142. As of Q4 2014, QUINIDINE remains US FDA's Preferred Term for this commodity. Quinidine bears US NLM identifiers UMLS ID C0034414 and NCI Concept Code C793. SMILES: OC(C1N2CC(C(C1)CC2)C=C)C1C2C(NCC1)CCC(OC)C2.OC(C(O)C(O)C(=O)O)C(O)CO.

UNSPSC 51124302 Quinidine, a Commodity code, encompasses prescription and emergency-use medications that state and local governments procure for healthcare delivery, emergency response, and pharmacy benefit programs. Recent solicitations show state and local buyers purchasing specific pharmaceutical line items—epinephrine, adenosine, labetalol, diltiazem, and other advanced life support medications—through sealed competitive bids, cooperative purchasing frameworks, and direct-to-manufacturer contracting initiatives. The issuing bodies include municipal fire rescue services, state health and human services agencies, and multistate cooperative purchasing alliances; Tampa Fire Rescue (via the City of Tampa Purchasing Department), the Texas Health and Human Services Commission, and the Minnesota Department of Administration's Office of State Procurement appear as recent active buyers. Solicitations require vendors to meet FDA compliance, Good Manufacturing Practices (cGMP) certification, Drug Supply Chain Security Act (DSCSA) compliance, OSHA Hazard Communication Standards for Safety Data Sheets, and federal accessibility standards (WCAG 2.2 Level AA and Section 508).

Activity spans Florida, Texas, Minnesota, Oregon, and other cooperative purchasing jurisdictions. The City of Tampa issued an IFB (Solicitation No. 26P00188) for Advanced Life Support Medications on April 24, 2026, with a response deadline of April 8, 2026 and an estimated contract value of $40,000, requiring delivery within ten calendar days and nine-month minimum expiration dates; the award includes a Small Local Business Enterprise (SLBE) sheltered market designation with a 5 percent bid discount not to exceed $10,000. The Texas Health and Human Services Commission issued an RFI (HHS0017013) on April 3, 2026 to assess vendor capabilities for direct-to-manufacturer prescription contracting outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP (S1070000015802) due March 26, 2026 for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local facilities in Minnesota and Oregon, with awarded contracts effective July 1, 2026 and a two-year initial term; vendors must maintain relationships with authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, Morris & Dickson) and pay a 3 percent administrative fee.